Evaluating functional disability in clinical trials of lisdexamfetamine dimesylate in binge eating disorder using the Sheehan Disability Scale

OBJECTIVES: This study examined Sheehan Disability Scale (SDS) performance in binge eating disorder (BED) and explored relationships between SDS and BED outcomes using data from three placebo‐controlled lisdexamfetamine (LDX) studies (two short‐term, dose‐optimized studies and one double‐blind, rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Karen S., Pokrzywinski, Robin, Hareendran, Asha, Shaffer, Shannon, Sheehan, David V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992284/
https://www.ncbi.nlm.nih.gov/pubmed/32841462
http://dx.doi.org/10.1002/mpr.1849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992284/
https://www.ncbi.nlm.nih.gov/pubmed/32841462
http://dx.doi.org/10.1002/mpr.1849

Ejemplares similares